New studies conclude Xlear kills and/or deactivates SARS-CoV-2
MIAMI — New in vitro studies, led by renowned authority on respiratory diseases, conclude Xlear nasal spray is “an effective…and replicable means to deactivate SARS-CoV-2…to an undetectable amount of infectious virus.” This conclusion is “validated by two independent sets of experiments, performed by different labs, on different viral strains…” The Virucidal studies were independently funded.
